Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death

American Journal of Cardiology

Volumn 111, Issue 9, 2013, Pages 1319-1323

  Kreuz, Jens ^a   Skowasch, Dirk ^a   Horlbeck, Fritz ^a   Atzinger, Carolin ^a   Schrickel, Jan W ^a   Lorenzen, Henning ^b   Nickenig, Georg ^a   Schwab, Jörg O ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; BODY MASS; CARDIAC RESYNCHRONIZATION THERAPY; EPWORTH SLEEPINESS SCALE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; OBESITY; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK FACTOR; SLEEP DISORDERED BREATHING; SUDDEN DEATH;

ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; PRIMARY PREVENTION; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SLEEP APNEA SYNDROMES; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84876707598     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.01.277     Document Type: Article

References (27)

1. D.P. Zipes, A.J. Camm, M. Borggrefe, A.E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A.J. Moss, R.J. Myerburg, S.G. Priori, M.A. Quinones, D.M. Roden, M.J. Silka, C. Tracy, S.G. Priori, J.J. Blanc, A. Budaj, A.J. Camm, V. Dean, J.W. Deckers, C. Despres, K. Dickstein, J. Lekakis, K. McGregor, M. Metra, J. Morais, A. Osterspey, J.L. Tamargo, J.L. Zamorano, S.C. Smith Jr., A.K. Jacobs, C.D. Adams, E.M. Antman, J.L. Anderson, S.A. Hunt, J.L. Halperin, R. Nishimura, J.P. Ornato, R.L. Page, B. Riegel American College of Cardiology, American Heart Association Task Force, European Society of Cardiology Committee for Practice Guidelines, European Heart Rhythm Association, Heart Rhythm Society ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace 8 2006 746 837
2. A.J. Moss, W. Zareba, W.J. Hall, H. Klein, D.J. Wilber, D.S. Cannom, J.P. Daubert, S.L. Higgins, M.W. Brown, and M.L. Andrews Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
3. G.H. Bardy, K.L. Lee, D.B. Mark, J.E. Poole, D.L. Packer, R. Boineau, M. Domanski, C. Troutman, J. Anderson, G. Johnson, S.E. McNulty, N. Clapp-Channing, L.D. Davidson-Ray, E.S. Fraulo, D.P. Fishbein, R.M. Luceri, and J.H. Ip Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
4. A.E. Buxton, K.L. Lee, J.D. Fisher, M.E. Josephson, E.N. Prystowsky, and G. Hafley A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators N Engl J Med 341 1999 1882 1890
5. A. Kadish, A. Dyer, J.P. Daubert, R. Quigg, N.A. Estes, K.P. Anderson, H. Calkins, D. Hoch, J. Goldberger, A. Shalaby, W.E. Sanders, A. Schaechter, and J.H. Levine Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 2004 2151 2158
6. J.E. Poole, G.W. Johnson, A.S. Hellkamp, J. Anderson, D.J. Callans, M.H. Raitt, R.K. Reddy, F.E. Marchlinski, R. Yee, T. Guarnieri, M. Talajic, D.J. Wilber, D.P. Fishbein, D.L. Packer, D.B. Mark, K.L. Lee, and G.H. Bardy Prognostic importance of defibrillator shocks in patients with heart failure N Engl J Med 359 2008 1009 1017
7. H. Desai, W.S. Aronow, C. Ahn, K. Gandhi, S. Hussain, H.M. Lai, M. Sharma, W.H. Frishman, M. Cohen, and C. Sorbera Risk factors for appropriate cardioverter-defibrillator shocks, inappropriate cardioverter-defibrillator shocks, and time to mortality in 549 patients with heart failure Am J Cardiol 105 2010 1336 1368
8. J. Kreuz, O. Balta, M. Linhart, R. Fimmers, L. Lickfett, F. Mellert, G. Nickenig, and J.O. Schwab An impaired renal function and advanced heart failure represent independent predictors of the incidence of malignant ventricular arrhythmias in patients with an implantable cardioverter/defibrillator for primary prevention Europace 12 2010 1439 1445
9. R. Schulz, A. Blau, J. Börgel, H.W. Duchna, I. Fietze, I. Koper, R. Prenzel, S. Schädlich, J. Schmitt, S. Tasci, S. Andreas Working Group Kreislauf und Schlaf of the German Sleep Society (DGSM) Sleep apnoea in heart failure Eur Respir J 29 2007 1201 1205
10. H. Wang, J.D. Parker, G.E. Newton, J.S. Floras, S. Mak, K.L. Chiu, P. Ruttanaumpawan, G. Tomlinson, and T.D. Bradley Influence of obstructive sleep apnea on mortality in patients with heart failure J Am Coll Cardiol 49 2007 1625 1631
11. N. Takama, and M. Kurabayashi Influence of untreated sleep-disordered breathing on the long-term prognosis of patients with cardiovascular disease Am J Cardiol 103 2009 730 734
12. K. Jongnarangsin, A. Chugh, E. Good, S. Mukerji, S. Dey, T. Crawford, J.F. Sarrazin, M. Kuhne, N. Chalfoun, D. Wells, W. Boonyapisit, F. Pelosi Jr., F. Bogun, F. Morady, and H. Oral Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation J Cardiovasc Electrophysiol 19 2008 668 672
13. M. Matiello, M. Nadal, D. Tamborero, A. Berruezo, J. Montserrat, C. Embid, J. Rios, J. Villacastín, J. Brugada, and L. Mont Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients Europace 12 2010 1084 1089
14. C.Y. Ng, T. Liu, M. Shehata, S. Stevens, S.S. Chugh, and X. Wang Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation Am J Cardiol 108 2011 47 51
15. F.F. Hoyer, L.M. Lickfett, E. Mittmann-Braun, C. Ruland, J. Kreuz, S. Pabst, J. Schrickel, U. Juergens, S. Tasci, G. Nickenig, and D. Skowasch High prevalence of obstructive sleep apnea in patients with resistant paroxysmal atrial fibrillation after pulmonary vein isolation J Interv Card Electrophysiol 29 2010 37 41
16. N. Serizawa, D. Yumino, K. Kajimoto, Y. Tagawa, A. Takagi, M. Shoda, H. Kasanuki, and N. Hagiwara Impact of sleep-disordered breathing on life-threatening ventricular arrhythmia in heart failure patients with implantable cardioverter-defibrillator Am J Cardiol 102 2008 1064 1068
17. T. Zeidan-Shwiri, D. Aronson, K. Atalla, M. Blich, M. Suleiman, I. Marai, L. Gepstein, L. Lavie, P. Lavie, and M. Boulos Circadian pattern of life-threatening ventricular arrhythmia in patients with sleep-disordered breathing and implantable cardioverter-defibrillators Heart Rhythm 8 2011 657 662
18. J. Fichter, D. Bauer, S. Arampatzis, R. Fries, A. Heisel, and G.W. Sybrecht Sleep-related breathing disorders are associated with ventricular arrhythmias in patients with an implantable cardioverter-defibrillator Chest 122 2002 558 561
19. T. Bitter, N. Westerheide, C. Prinz, M.S. Hossain, J. Vogt, C. Langer, D. Horstkotte, and O. Oldenburg Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure Eur Heart J 32 2011 61 74
20. M.W. Johns A new method for measuring daytime sleepiness: the Epworth sleepiness scale Sleep 14 1991 540 545
21. V.L. Cooper, S.B. Pearson, C.M. Bowker, M.W. Elliott, and R. Hainsworth Interaction of chemoreceptor and baroreceptor reflexes by hypoxia and hypercapnia - a mechanism for promoting hypertension in obstructive sleep apnoea J Physiol 568 2005 677 687
22. K. Narkiewicz, and V.K. Somers Sympathetic nerve activity in obstructive sleep apnoea Acta Physiol Scand 177 2003 385 390
23. K. Narkiewicz, P.J. van de Borne, C.A. Pesek, M.E. Dyken, N. Montano, and V.K. Somers Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea Circulation 99 1999 1183 1189
24. O. Oldenburg, and D. Horstkotte Respiratory instability in patients with chronic heart failure J Am Coll Cardiol 56 2010 1838 1839
25. B.L. Wilkoff, K.T. Ousdigian, L.D. Sterns, Z.J. Wang, R.D. Wilson, J.M. Morgan EMPIRIC Trial Investigators A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial J Am Coll Cardiol 48 2006 330 339
26. B.L. Wilkoff, B.D. Williamson, R.S. Stern, S.L. Moore, F. Lu, S.W. Lee, U.M. Birgersdotter-Green, M.S. Wathen, I.C. Van Gelder, B.M. Heubner, M.L. Brown, K.K. Holloman PREPARE Study Investigators Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study J Am Coll Cardiol 52 2008 541 550
27. N.F. Marrouche, J. Brachmann CASTLE-AF Steering Committee Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation (CASTLE-AF) - study design Pacing and Clinical Electrophysiology 32 2009 987 994